Cargando…
Excision of Integrated Human Herpesvirus 6A Genomes Using CRISPR/Cas9 Technology
Human herpesviruses 6A and 6B are betaherpesviruses that can integrate their genomes into the telomeres of latently infected cells. Integration can also occur in germ cells, resulting in individuals who harbor the integrated virus in every cell of their body and can pass it on to their offspring. Th...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100985/ https://www.ncbi.nlm.nih.gov/pubmed/36926973 http://dx.doi.org/10.1128/spectrum.00764-23 |
_version_ | 1785025407801622528 |
---|---|
author | Aimola, Giulia Wight, Darren J. Flamand, Louis Kaufer, Benedikt B. |
author_facet | Aimola, Giulia Wight, Darren J. Flamand, Louis Kaufer, Benedikt B. |
author_sort | Aimola, Giulia |
collection | PubMed |
description | Human herpesviruses 6A and 6B are betaherpesviruses that can integrate their genomes into the telomeres of latently infected cells. Integration can also occur in germ cells, resulting in individuals who harbor the integrated virus in every cell of their body and can pass it on to their offspring. This condition is termed inherited chromosomally integrated HHV-6 (iciHHV-6) and affects about 1% of the human population. The integrated HHV-6A/B genome can reactivate in iciHHV-6 patients and in rare cases can also cause severe diseases including encephalitis and graft-versus-host disease. Until now, it has remained impossible to prevent virus reactivation or remove the integrated virus genome. Therefore, we developed a system that allows the removal of HHV-6A from the host telomeres using the CRISPR/Cas9 system. We used specific guide RNAs (gRNAs) targeting the direct repeat region at the ends of the viral genome to remove the virus from latently infected cells generated in vitro and iciHHV-6A patient cells. Fluorescence-activated cell sorting (FACS), quantitative PCR (qPCR), and fluorescence in situ hybridization (FISH) analyses revealed that the virus genome was efficiently excised and lost in most cells. Efficient excision was achieved with both constitutive and transient expression of Cas9. In addition, reverse transcription-qPCR (RT-qPCR) revealed that the virus genome did not reactivate upon excision. Taken together, our data show that our CRISPR/Cas9 approach allows efficient removal of the integrated virus genome from host telomeres. IMPORTANCE Human herpesvirus 6 (HHV-6) infects almost all humans and integrates into the telomeres of latently infected cells to persist in the host for life. In addition, HHV-6 can also integrate into the telomeres of germ cells, which results in about 80 million individuals worldwide who carry the virus in every cell of their body and can pass it on to their offspring. In this study, we develop the first system that allows excision of the integrated HHV-6 genome from host telomeres using CRISPR/Cas9 technology. Our data revealed that the integrated HHV-6 genome can be efficiently removed from the telomeres of latently infected cells and cells of patients harboring the virus in their germ line. Virus removal could be achieved with both stable and transient Cas9 expression, without inducing viral reactivation. |
format | Online Article Text |
id | pubmed-10100985 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-101009852023-04-14 Excision of Integrated Human Herpesvirus 6A Genomes Using CRISPR/Cas9 Technology Aimola, Giulia Wight, Darren J. Flamand, Louis Kaufer, Benedikt B. Microbiol Spectr Research Article Human herpesviruses 6A and 6B are betaherpesviruses that can integrate their genomes into the telomeres of latently infected cells. Integration can also occur in germ cells, resulting in individuals who harbor the integrated virus in every cell of their body and can pass it on to their offspring. This condition is termed inherited chromosomally integrated HHV-6 (iciHHV-6) and affects about 1% of the human population. The integrated HHV-6A/B genome can reactivate in iciHHV-6 patients and in rare cases can also cause severe diseases including encephalitis and graft-versus-host disease. Until now, it has remained impossible to prevent virus reactivation or remove the integrated virus genome. Therefore, we developed a system that allows the removal of HHV-6A from the host telomeres using the CRISPR/Cas9 system. We used specific guide RNAs (gRNAs) targeting the direct repeat region at the ends of the viral genome to remove the virus from latently infected cells generated in vitro and iciHHV-6A patient cells. Fluorescence-activated cell sorting (FACS), quantitative PCR (qPCR), and fluorescence in situ hybridization (FISH) analyses revealed that the virus genome was efficiently excised and lost in most cells. Efficient excision was achieved with both constitutive and transient expression of Cas9. In addition, reverse transcription-qPCR (RT-qPCR) revealed that the virus genome did not reactivate upon excision. Taken together, our data show that our CRISPR/Cas9 approach allows efficient removal of the integrated virus genome from host telomeres. IMPORTANCE Human herpesvirus 6 (HHV-6) infects almost all humans and integrates into the telomeres of latently infected cells to persist in the host for life. In addition, HHV-6 can also integrate into the telomeres of germ cells, which results in about 80 million individuals worldwide who carry the virus in every cell of their body and can pass it on to their offspring. In this study, we develop the first system that allows excision of the integrated HHV-6 genome from host telomeres using CRISPR/Cas9 technology. Our data revealed that the integrated HHV-6 genome can be efficiently removed from the telomeres of latently infected cells and cells of patients harboring the virus in their germ line. Virus removal could be achieved with both stable and transient Cas9 expression, without inducing viral reactivation. American Society for Microbiology 2023-03-16 /pmc/articles/PMC10100985/ /pubmed/36926973 http://dx.doi.org/10.1128/spectrum.00764-23 Text en Copyright © 2023 Aimola et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Aimola, Giulia Wight, Darren J. Flamand, Louis Kaufer, Benedikt B. Excision of Integrated Human Herpesvirus 6A Genomes Using CRISPR/Cas9 Technology |
title | Excision of Integrated Human Herpesvirus 6A Genomes Using CRISPR/Cas9 Technology |
title_full | Excision of Integrated Human Herpesvirus 6A Genomes Using CRISPR/Cas9 Technology |
title_fullStr | Excision of Integrated Human Herpesvirus 6A Genomes Using CRISPR/Cas9 Technology |
title_full_unstemmed | Excision of Integrated Human Herpesvirus 6A Genomes Using CRISPR/Cas9 Technology |
title_short | Excision of Integrated Human Herpesvirus 6A Genomes Using CRISPR/Cas9 Technology |
title_sort | excision of integrated human herpesvirus 6a genomes using crispr/cas9 technology |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100985/ https://www.ncbi.nlm.nih.gov/pubmed/36926973 http://dx.doi.org/10.1128/spectrum.00764-23 |
work_keys_str_mv | AT aimolagiulia excisionofintegratedhumanherpesvirus6agenomesusingcrisprcas9technology AT wightdarrenj excisionofintegratedhumanherpesvirus6agenomesusingcrisprcas9technology AT flamandlouis excisionofintegratedhumanherpesvirus6agenomesusingcrisprcas9technology AT kauferbenediktb excisionofintegratedhumanherpesvirus6agenomesusingcrisprcas9technology |